Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.13 USD | +0.47% | -13.77% | -29.24% |
May. 06 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
Financials (USD)
Sales 2024 * | 4.45M | Sales 2025 * | 1.27M | Capitalization | 117M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -92M | EV / Sales 2024 * | -2.13 x |
Net cash position 2024 * | 127M | Net cash position 2025 * | 30.93M | EV / Sales 2025 * | 68.1 x |
P/E ratio 2024 * |
-1.69
x | P/E ratio 2025 * |
-1.76
x | Employees | 94 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.08% |
Latest transcript on Omega Therapeutics, Inc.
1 day | +0.47% | ||
1 week | -13.77% | ||
Current month | -4.48% | ||
1 month | -6.17% | ||
3 months | -49.53% | ||
6 months | +13.90% | ||
Current year | -29.24% |
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Karande
CEO | Chief Executive Officer | 51 | 19-05-31 |
Joshua Reed
DFI | Director of Finance/CFO | 51 | 22-05-22 |
Samir Padalkar
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Luke Beshar
BRD | Director/Board Member | 65 | 21-04-30 |
John Mendlein
BRD | Director/Board Member | 64 | 19-12-31 |
Christian Schade
CHM | Chairman | 63 | 23-07-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 2.13 | +0.47% | 540,008 |
24-05-23 | 2.12 | -4.93% | 491,273 |
24-05-22 | 2.23 | +1.83% | 382,223 |
24-05-21 | 2.19 | -11.34% | 493,658 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.24% | 117M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.93% | 40.47B | |
-10.87% | 27.17B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- OMGA Stock